Key result
Liposomal Amphotericin B and Flucytosine successfully resolve a case of Candida tropicalis defibrillator endocarditis.
Case Report (n=1)
No
Successful medical management of C. tropicalis defibrillator endocarditis with liposomal Amphotericin B and Flucytosine for 8 weeks in a patient refusing surgical intervention.
Answers are grounded in this paper and cite their sources.
May allow nonsurgical management of Candida tropicalis defibrillator endocarditis when surgery is declined; leaves open need for prospective validation.
We provide a review of current literature and report on a case of electronic device infective endocarditis with C. tropicalis. A 64-year-old man presented for revision of his implantable cardioverter defibrillator. Echocardiography revealed extensive vegetations attached to the Eustachian valve and in the right ventricular apex. Microbiological findings presented C. tropicalis on the explanted material. The patient refused additional surgical intervention. We successfully treated the patient with liposomal Amphotericin B and Flucytosine for 8 weeks.
No takes yet. Share an insight, caveat, or question.
Bauer et al. (2019) conducted a case report in Candida tropicalis defibrillator endocarditis (n=1). Liposomal Amphotericin B and Flucytosine was evaluated on Clinical cure and absence of relapse. An 8-week course of liposomal Amphotericin B and Flucytosine successfully treated a 64-year-old man with Candida tropicalis defibrillator endocarditis, with no relapse at 14 months follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: